BF-03-RM76_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-[[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)carbamoyl]amino]benzamide, Angiogenesis Inhibitors;Bcr-Abl Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Flt3 (FLK2/STK1) Inhibitors;FGFR3 Inhibitors targeting ABL1, BCR, FGFR3, FLT3, ABL2 (Novartis, 16085322)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/16085322
Similar Terms
Downloads & Tools

Genes

11 genes differentially expressed following the BF-03-RM76_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
KRTAP2-3 keratin associated protein 2-3 0.540517
TIMP1 TIMP metallopeptidase inhibitor 1 0.540517
MT2A metallothionein 2A 0.491751
TGM2 transglutaminase 2 0.449014
UPP1 uridine phosphorylase 1 0.233406
ZNF593 zinc finger protein 593 0.203667
GLRX glutaredoxin (thioltransferase) 0.201033

decreased expression

Symbol Name Standardized Value
TMSB4X thymosin beta 4, X-linked -0.542011
CPA4 carboxypeptidase A4 -0.473708
BMP4 bone morphogenetic protein 4 -0.278641
MN1 meningioma (disrupted in balanced translocation) 1 -0.242248